Ginkgo Bioworks Holdings, Inc. (DNA) closed at $10.02 in the latest trading session, marking a -6.36% move from the prior day ...

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are surging Tuesday after the company announced the launch of its new protein large language model (LLM) built on Google Cloud. What Happened: Ginkgo ...

Which of Ginkgo's bad news was worse? I suspect the Ark Invest sales of Ginkgo stock worried investors more than the company's staffing cuts. Ginkgo announced in its first-quarter update on May 9 that ...

Shares of Ginkgo Bioworks Holdings (NYSE:DNA) fell in the premarket on Friday after the cell platform company scheduled a meeting to obtain shareholder approval for a proposed reverse stock split. The ...

Ginkgo Bioworks (NYSE: DNA) stock has had a rough 12 months, falling 88%, and undergoing a reverse stock split on Aug. 20 that left its shares down by around 18% in the aftermath. Depending on which ...

Ginkgo Bioworks shares dropped on Friday as revenue growth continues to disappoint and cash burn persists despite improvements. Q3 results missed expectations, with adjusted revenues tumbling and ...

Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares continue to trade higher after rising nearly 10% on Tuesday. Here’s a look at what’s going on. What To Know: Ginkgo Bioworks shares appear to be getting ...

To say the past year has been rough for investors in Ginkgo Bioworks (NYSE: DNA) would be an understatement of the highest order. As of Aug 14, shares of the synthetic-biology stock were down by 86% ...

Ginkgo Bioworks Holdings, Inc. (DNA) closed at $9.06 in the latest trading session, marking a -5.72% move from the prior day. This move lagged the S&P 500's daily gain of 0.01%. Elsewhere, the Dow saw ...